Wellcome Trust & EBI, Wellcome Trust Conference Centre, Hinxton, Cambridge, UK
1st - 3rd March 2010
SESSION 1: NOT-FOR-PROFIT DRUG DISCOVERY (chairs: Alexander Tropsha, Paul Wyatt) · Alexander Tropsha, University of North Carolina at Chapel Hill · Paul Wyatt, University of Dundee · Brian Walker, University of Edinburgh · Dennis Liotta, Emory University SESSION 2: LARGE-SCALE PREDICTIVE APPROACHES (chair: Tudor Oprea) · Tudor Oprea, University of New Mexico: Ligand–Protein interaction networks · Søren Brunak, Danish Technical University: Protein–protein interactions · Chris Austin, US National Human Genome Research Institute: the NCGC approach to early discovery · Jon Mason, Heptares: understanding polypharmacology · Scott Boyer, AZ Goteborg: using metabolic networks to understand drug safety SESSION 3: PHYSIOLOGICAL AND METABOLIC SYSTEMS BIOLOGY (chair: Jeremy Nicholson) · Jeremy Nicholson, Imperial College, London, UK · Nicolas Le Novère, EMBL-European Bioinformatics Institute, Hinxton, UK · David Wishart, University of Alberta, Canada SESSION 4: PUBLIC INFRASTRUCTURE FOR SCREENING (chair: Steve Bryant) · Steve Bryant, US National Center for Biotecnology Information · Mark Scheideler, US National Institutes of Health: NIH Molecular Library’s grant solicitation for screening bioassays · Ronald Frank, Leibniz-Institut für Molekulare Pharmakologie: EU-OpenScreen · Heather Carlson: CSAR, Community Structure-Activity Resource · Ann Richard: US EPA’s toxicology resources · Anthony Williams: ChemSpider
|